We are live on
!
Find out more
AICPI
ABG Innovation Capital Partners III Portfolio holdings
AUM
$64.5K
1-Year Est. Return
1.01%
This Fund
S&P 500
This Quarter
Est. Return
+23.16%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
–
AUM
$900K
AUM Growth
+$164K
(+22%)
Cap. Flow
+$54.9K
Cap. Flow
% of AUM
6.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Castle Biosciences
CSTL
|
+$54.9K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
FFVM
SNN
AC
MI
FFVM
FFVM
NA
IVSFI
ABG Innovation Capital Partners III's Q4 2023 Portfolio in Review
As of Q4 2023, ABG Innovation Capital Partners III held 3 positions worth $900K, up 22% from $736K the previous quarter. Its ten largest holdings account for 100% of the portfolio.
ABG Innovation Capital Partners III deployed $54.9K of net new capital in Q4 2023, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- ABG Innovation Capital Partners III added most to Castle Biosciences in Q4 2023, an estimated $54.9K increase.
- ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $900K portfolio in Q4 2023.
- ABG Innovation Capital Partners III opened 0 new positions and closed 0 in Q4 2023.
- ABG Innovation Capital Partners III's portfolio value rose 22% quarter-over-quarter to $900K.
Based on ABG Innovation Capital Partners III's 13F filing for Q4 2023, filed 14 Feb 2024.